RFL Stock - Rafael Holdings, Inc.
Unlock GoAI Insights for RFL
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $917,000 | $637,000 | $279,000 | $410,000 | $3.97M |
| Gross Profit | $495,000 | $483,000 | $279,000 | $410,000 | $3.90M |
| Gross Margin | 54.0% | 75.8% | 100.0% | 100.0% | 98.2% |
| Operating Income | $-26,109,000 | $-102,627,000 | $-15,043,000 | $-60,477,000 | $-29,812,000 |
| Net Income | $-30,520,000 | $-34,410,000 | $-1,876,000 | $-124,658,000 | $-25,149,000 |
| Net Margin | -3328.2% | -5401.9% | -672.4% | -30404.4% | -633.3% |
| EPS | $-1.04 | $-1.45 | $-0.08 | $-6.31 | $-1.52 |
Rafael Holdings, Inc. holds interests in clinical and early stage pharmaceutical companies, and commercial real estate assets in the United States and Israel. The company operates in two segments, Pharmaceuticals and Real Estate. It engages in the leasing of a commercial office building, as well as an associated 800-car public garage; and development and commercialization of therapies that exploit the metabolic differences between normal cells and cancer cells. The company's lead drug candidate is CPI-613 (devimistat), which is being evaluated in various clinical studies, including two Phase III registrational clinical trials for the treatment of metastatic pancreatic cancer and r/r acute myeloid leukemia. Rafael Holdings, Inc. is headquartered in Newark, New Jersey.
Visit WebsiteEarnings History & Surprises
RFLEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q1 2026 | Mar 11, 2026 | — | — | — | — |
Q4 2025 | Dec 11, 2025 | — | $-0.19 | — | — |
Q4 2025 | Oct 29, 2025 | — | $-0.28 | — | — |
Q2 2025 | Jun 11, 2025 | — | $-0.19 | — | — |
Q1 2025 | Mar 13, 2025 | — | $-0.06 | — | — |
Q4 2024 | Dec 11, 2024 | — | $-0.37 | — | — |
Q4 2024 | Nov 6, 2024 | — | $-0.19 | — | — |
Q2 2024 | Jun 14, 2024 | — | $-1.36 | — | — |
Q1 2024 | Mar 13, 2024 | — | $-0.08 | — | — |
Q4 2023 | Dec 14, 2023 | — | $-0.08 | — | — |
Q4 2023 | Oct 30, 2023 | — | $0.06 | — | — |
Q2 2023 | Jun 13, 2023 | — | $-0.06 | — | — |
Q1 2023 | Mar 14, 2023 | — | $-0.13 | — | — |
Q4 2022 | Dec 13, 2022 | — | $-0.22 | — | — |
Q4 2022 | Oct 31, 2022 | — | $-0.24 | — | — |
Q2 2022 | Jun 14, 2022 | — | $-0.28 | — | — |
Q1 2022 | Mar 17, 2022 | — | $-0.12 | — | — |
Q4 2021 | Dec 15, 2021 | — | $-2.52 | — | — |
Q4 2021 | Oct 18, 2021 | — | $-0.75 | — | — |
Q2 2021 | Jun 14, 2021 | — | $-0.15 | — | — |
Latest News
Frequently Asked Questions about RFL
What is RFL's current stock price?
What is the analyst price target for RFL?
What sector is Rafael Holdings, Inc. in?
What is RFL's market cap?
Does RFL pay dividends?
Similar Stocks
Real Estate SectorExplore stocks similar to RFL for comparison